These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37051543)

  • 1. Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer.
    Zhou X; Liu Y; Tan J; Hu L; Chen H; Wan C
    Front Oncol; 2023; 13():1123258. PubMed ID: 37051543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing Minimal Clinically Important Differences for the Quality of Life Instrument in Patients With Breast Cancer QLICP-BR (V2.0) Based on Anchor-Based and Distribution-Based Methods.
    Li F; Liu Y; Wan C; Zhou J; Tan J; Chen H
    Front Oncol; 2022; 12():753729. PubMed ID: 35586490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the methods of establishing the minimum clinical important difference based on anchor and its application in the quality of life measurement scale QLICP-ES (V2.0) for esophageal cancer.
    Ren D; Wu T; Wan C; Li G; Qi Y; Fang Y; Zhong J
    Health Qual Life Outcomes; 2021 Jul; 19(1):173. PubMed ID: 34215267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
    Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
    Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
    Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing minimal clinically important differences for the quality of life scale QLICD-SLE for patients with systemic lupus erythematosus based on ROC curve.
    Liu Y; Xue H; Wong W; Ding H; Chen M; Xie T; Wan C
    Sci Rep; 2024 Sep; 14(1):20982. PubMed ID: 39251635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the quality of life in patients with breast cancer at different TNM stages after standardized treatment].
    Huang R; Huang Y; Tao P; Li H; Wang Q; Li H; Li JY
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):71-7. PubMed ID: 23648306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods.
    Wu X; Chen Y; Wan C; Yu L; Lei P; Sun X
    BMC Gastroenterol; 2023 May; 23(1):149. PubMed ID: 37173655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of the Breast Cancer Scale QLICP-BR V2.0 Based on Classical Test Theory and Generalizability Theory.
    Li F; Zhou J; Wan C; Yang Z; Liang Q; Li W; Chen H
    Front Oncol; 2022; 12():915103. PubMed ID: 35769719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anchor design of anchor-based method to determine the minimal clinically important difference: a systematic review.
    Zhang Y; Xi X; Huang Y
    Health Qual Life Outcomes; 2023 Jul; 21(1):74. PubMed ID: 37454099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
    Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.
    Cheung YT; Foo YL; Shwe M; Tan YP; Fan G; Yong WS; Madhukumar P; Ooi WS; Chay WY; Dent RA; Ang SF; Lo SK; Yap YS; Ng R; Chan A
    J Clin Epidemiol; 2014 Jul; 67(7):811-20. PubMed ID: 24656406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease.
    Parker SL; Mendenhall SK; Shau D; Adogwa O; Cheng JS; Anderson WN; Devin CJ; McGirt MJ
    J Neurosurg Spine; 2012 Jan; 16(1):61-7. PubMed ID: 21962034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.
    Wu J; Hu L; Zhang G; Liang Q; Meng Q; Wan C
    Qual Life Res; 2016 Aug; 25(8):2087-100. PubMed ID: 26928910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
    Ogura K; Yakoub MA; Christ AB; Fujiwara T; Nikolic Z; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2020 Sep; 478(9):2148-2158. PubMed ID: 32568896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis: insights from the Quality Outcomes Database.
    Asher AL; Kerezoudis P; Mummaneni PV; Bisson EF; Glassman SD; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Coric D; Knightly JJ; Park P; Fu KM; Devin CJ; Archer KR; Chotai S; Chan AK; Virk MS; Bydon M
    Neurosurg Focus; 2018 Jan; 44(1):E2. PubMed ID: 29290132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients.
    Chan A; Yo TE; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    J Pain Symptom Manage; 2018 Mar; 55(3):992-997.e2. PubMed ID: 29097274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.
    Parker SL; Adogwa O; Mendenhall SK; Shau DN; Anderson WN; Cheng JS; Devin CJ; McGirt MJ
    Spine J; 2012 Dec; 12(12):1122-8. PubMed ID: 23158968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum Clinically Important Differences of the Hospital for Special Surgery Dysphagia and Dysphonia Inventory and Other Dysphagia Measurements in Patients Undergoing ACDF.
    Okano I; Ortiz Miller C; Salzmann SN; Hoshino Y; Shue J; Sama AA; Cammisa FP; Girardi FP; Hughes AP
    Clin Orthop Relat Res; 2020 Oct; 478(10):2309-2320. PubMed ID: 32282534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.